Keywords: sb, trading, profit, up, new, prods, smithkline

SB Trading Profit Up 19% On New Prods

Article | 26 February 1996

SmithKline Beecham saw sales rise 16% to L7.01 billion ($11.08 billion) for 1995, with trading profit from continuing operations escalating 19% to L1.47 billion ($2.32 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Tagamet

Cimetidine

Nabumetone

Relafen

Kytril

Go to drug listing